Customize your JAMA Network experience by selecting one or more topics from the list below.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—In the report of the Council on Pharmacy and Chemistry "Ferro-Copral Tablets Not Acceptable for N. N. R." (The Journal, March 5, p. 816) the claimed amounts of two of the ingredients (saccharated ferric oxide-N. F. and manganese citrate) were incorrectly reported as respectively 1 and 10 grains per tablet. The report should have brought out that the tablets are stated to contain saccharated ferric oxide-N. F. 10 grains and manganese citrate 1 grain. The report was also incorrect in that the copper proteinate constituent of the tablets was stated to have been prepared by the interaction of egg albumin and copper citrate. The report should have brought out that the copper proteinate was stated to have been prepared by the interaction of egg albumin and copper acetate.
Ferro-Copral Tablets. JAMA. 1932;98(14):1158. doi:10.1001/jama.1932.02730400036011
Create a personal account or sign in to: